CorMedix Inc. Balance Sheet
CRMD|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
CorMedix Inc. had $826M in total assets and $405M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $144.8M | $40.7M | $43.6M | $43.1M | $53.3M | $41.9M | $16.4M | $17.6M | $10.4M | $11.8M | $11.8M | $4.3M | $0 |
| Accounts Receivable | $171.2M | $51.7M | - | - | $45.4K | $3.4K | $35 | - | $64.1K | $12.0K | $315.8K | $80.2K | $2.3K |
| Inventory | $29.7M | $7.6M | $2.1M | - | $3.0K | $143.6K | $338.5K | $428.5K | $594.2K | $166.7K | $376.6K | $463.0K | $80.0K |
| Current Assets | $367.1M | $114.6M | $79.5M | $59.6M | $66.5M | $48.2M | $29.3M | $18.7M | $13.3M | $21.8M | $37.1M | $5.0M | $2.9M |
| PP&E (Net) | $6.0M | $1.8M | $1.9M | $1.6M | $1.5M | $111.5K | $126.8K | $160.9K | $186.3K | $69.7K | $37.9K | $41.5K | $36.1K |
| Goodwill | $30.0M | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $826.1M | $118.8M | $82.1M | $62.0M | $68.9M | $49.3M | $29.5M | $18.8M | $13.5M | $21.9M | $37.1M | $5.1M | $3.0M |
| Current Liabilities | $174.3M | $33.8M | $11.4M | $6.3M | $5.3M | $4.2M | $5.8M | $7.8M | $6.3M | $4.1M | $3.1M | $1.4M | $1.7M |
| Shareholders' Equity | $405.3M | $84.7M | $70.1M | $62.8M | $44.2M | $23.6M | $4.9M | $7.2M | $17.8M | $34.0M | $34.0M | $3.6M | -$335.4K |